(DL)-3-O-Methyldopa

Modify Date: 2024-01-01 19:00:23

(DL)-3-O-Methyldopa Structure
(DL)-3-O-Methyldopa structure
 Common Name (DL)-3-O-Methyldopa
CAS Number 7636-26-2 Molecular Weight 211.214
Density 1.3±0.1 g/cm3 Boiling Point 407.3±45.0 °C at 760 mmHg
Molecular Formula C10H13NO4 Melting Point N/A
MSDS N/A Flash Point 200.1±28.7 °C

 Use of (DL)-3-O-Methyldopa


3-O-Methyl-DL-DOPA is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Epilepsy, Purine Nucleoside Phosphorylase Deficiency and Aromatic L Amino Acid Decarboxylase Deficiency[1][2][3][4].

 Names

Name 2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid
Synonym More Synonyms

 (DL)-3-O-Methyldopa Biological Activity

Description 3-O-Methyl-DL-DOPA is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Epilepsy, Purine Nucleoside Phosphorylase Deficiency and Aromatic L Amino Acid Decarboxylase Deficiency[1][2][3][4].
Related Catalog
In Vitro Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1].
References

[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720.  

[2]. Darin N, et al. Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy. Am J Hum Genet. 2016 Dec 1;99(6):1325-1337.  

[3]. Ormazabal A, et al. Pyridoxal 5'-phosphate values in cerebrospinal fluid: reference values and diagnosis of PNPO deficiency in paediatric patients. Mol Genet Metab. 2008 Jun;94(2):173-7.  

[4]. Abdenur JE, et al. Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis. Mol Genet Metab. 2006 Jan;87(1):48-53.  

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 407.3±45.0 °C at 760 mmHg
Molecular Formula C10H13NO4
Molecular Weight 211.214
Flash Point 200.1±28.7 °C
Exact Mass 211.084457
PSA 92.78000
LogP 0.08
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.591

 MSDS

Material Safety Data Sheet
Section1. Identification of the substance
Product Name: 3-Methoxy-DL-tyrosine
Synonyms:
Section2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
Section3. Composition/information on ingredients.
Ingredient name:3-Methoxy-DL-tyrosine
CAS number:7636-26-2
Section4. First aid measures
Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Section5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.
Section6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution:Wear approved mask/respirator
Hand precaution:Wear suitable gloves/gauntlets
Skin protection:Wear suitable protective clothing
Eye protection:Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.
Section7. Handling and storage
Handling:This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:
Section8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.
Section9. Physical and chemical properties
Appearance:Not specified
Boiling point:No data
No data
Melting point:
Flash point:No data
Density:No data
Molecular formula:C10H13NO4
Molecular weight:211.2
Section10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.
Section11. Toxicological information
No data.
Section12. Ecological information
No data.
Section13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.
Section14. Transportation information
Non-harzardous for air and ground transportation.
Section15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Risk Phrases 22-36/37/38
Safety Phrases 22-26-36/37/39
RIDADR NONH for all modes of transport

 Synthetic Route

N-[[4-(5-ethyl-1,3-benzoxazol-2-yl)phenyl]carbamothioyl]-4-methoxybenzamide structure

N-[[4-(5-ethyl-...

CAS#:6391-59-9

HYDROGEN CYANIDE structure

HYDROGEN CYANIDE

CAS#:74-90-8

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of the Chemical Society, , p. 1692,1694
(Z)-2-methoxy-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate structure

(Z)-2-methoxy-4...

CAS#:60470-82-8

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of Organic Chemistry, , vol. 23, p. 27,32
Pyruvic acid, (4-hydroxy-3-methoxyphenyl)-, 2-oxime structure

Pyruvic acid, (...

CAS#:5447-36-9

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of the Chemical Society, , p. 1795,1799
Acetyleugenol structure

Acetyleugenol

CAS#:93-28-7

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of the Chemical Society, , p. 1692,1694
Pyruvic acid, (4-hydroxy-3-methoxyphenyl)-2-thio- structure

Pyruvic acid, (...

CAS#:5438-45-9

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of the Chemical Society, , p. 1795,1799
5-vanillyl-imidazolidine-2,4-dione structure

5-vanillyl-imid...

CAS#:62682-19-3

~%

(DL)-3-O-Methyldopa Structure

(DL)-3-O-Methyldopa

CAS#:7636-26-2

Literature: Journal of the American Chemical Society, , vol. 35, p. 1611

 Articles25

More Articles
Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients.

Mov. Disord 26 , 543-546, (2011)

Oxidative stress is influenced by the thiol homeostasis, which determines the redox milieu. One of its components is Cysteinyl-glycine (Cys-Gly) generation, as its metabolic precursor is the free radi...

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

Clin. Neuropharmacol. 33(3) , 135-41, (2010)

The aims of the present study were to investigate the pharmacokinetic and pharmacodynamic (pk/pd) relationship of levodopa (l-dopa) in patients with advanced Parkinson disease (PD) and also to evaluat...

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial.

Eur. J. Neurol. 19(6) , 820-6, (2012)

Catechol-O-methyltransferase inhibitors may be used to decrease levodopa requirement. The objective was to investigate whether the levodopa/carbidopa intestinal gel infusion dose can be reduced by 20%...

 Synonyms

3-Methoxytyrosine
3-Methoxy-D,L-tyrosine
2-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid
3-Methoxy-tyrosine
Tyrosine, 3-methoxy-
3-METHOXY-DL-TYROSINE
UNII:SO86T1OB2P
3-O-Methyldopa
Top Suppliers:I want be here

Get all suppliers and price by the below link:

(DL)-3-O-Methyldopa suppliers

Price: ￥2437.5/10g

Reference only. check more (DL)-3-O-Methyldopa price

Related Compounds: More...
(R)-3-O-Methyldopa-d3 hydrochloride
2714485-35-3
(R)-3-O-Methyldopa-d3
1259947-39-1
(±)-Metanephrine
5001-33-2
(+/-)-3-O-benzyl-1,2:4,5-di-O,O-cyclohexylidene-myo-inositol
23393-20-6
3-O-Methyldopa D3
586954-09-8
DL-3,4-di-O-acetyl-(1,2,4/3,5)-5-bromomethyl-2-(toluene-p-sulfonamido)-1,3,4-cyclohexanetriol
80065-34-5
DL-3-Aminobutyric acid
2835-82-7
dl-3-amino-3-(2-cyano-phenyl)-propionic acid
682804-19-9
DL-3-Benzyloxycarbonylamino-glutarsaeuremonobenzylester
80902-50-7
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
3,4-Diethylcyclohexan-1-one
1824619-26-2
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,5-Trimethyl-4-phenyloxathiolane 2,2-dioxide
75732-44-4
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4
Chemsrc provides (DL)-3-O-Methyldopa(CAS#:7636-26-2) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of (DL)-3-O-Methyldopa are included as well.>> amp version: (DL)-3-O-Methyldopa

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved